Recursion Pharmaceuticals Inc (RXRX) Insider Trading
- $2,787,850.00
- $33,045,427.62
- Nov. 13, 2024
- Blake Borgeson
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| April 28, 2022 | CEO | 37,605 | $6.09 | Sell | $229,014.45 | |
| April 21, 2022 | CEO | 37,155 | $6.31 | Sell | $234,448.05 | |
| April 18, 2022 | CEO | 35,836 | $6.84 | Sell | $245,118.24 | |
| April 14, 2022 | CEO | 34,517 | $7.56 | Sell | $260,948.52 | |
| April 7, 2022 | CEO | 36,718 | $6.54 | Sell | $240,135.72 | |
| April 5, 2022 | CEO | 34,472 | $7.43 | Sell | $256,126.96 | |
| March 14, 2022 | CEO | 230,000 | $6.28 | Sell | $1,444,400.00 | |
| March 11, 2022 | CEO | 100,000 | $6.95 | Sell | $695,000.00 | |
| March 7, 2022 | CEO | 300,000 | $7.30 | Sell | $2,190,000.00 | |
| Feb. 22, 2022 | CEO | 100,000 | $10.22 | Sell | $1,022,000.00 | |
| Jan. 31, 2022 | CEO | 19,858 | $11.73 | Sell | $232,934.34 | |
| Jan. 13, 2022 | CEO | 87,000 | $14.33 | Sell | $1,246,710.00 | |
| Jan. 4, 2022 | Director | 9,625 | $18.03 | Sell | $173,538.75 | |
| Dec. 21, 2021 | Director | 9,625 | $18.75 | Sell | $180,468.75 | |
| Dec. 16, 2021 | COO | 2,500 | $18.74 | Sell | $46,850.00 | |
| Dec. 16, 2021 | CEO | 200 | $20.00 | Sell | $4,000.00 | |
| Dec. 13, 2021 | CEO | 100 | $20.02 | Sell | $2,002.00 | |
| Dec. 9, 2021 | CEO | 1,086 | $20.01 | Sell | $21,730.86 | |
| Dec. 7, 2021 | CEO | 3,125 | $20.51 | Sell | $64,093.75 | |
| Dec. 7, 2021 | Director | 9,625 | $20.32 | Sell | $195,580.00 | |
| Nov. 19, 2021 | Director | 13,474 | $20.20 | Sell | $272,174.80 | |
| Nov. 18, 2021 | COO | 2,500 | $18.92 | Sell | $47,300.00 | |
| Nov. 17, 2021 | Director | 5,626 | $20.04 | Sell | $112,745.04 |
Insiders are both buying and selling Recursion Pharmaceuticals Inc stock.
The insider traders at Recursion Pharmaceuticals Inc are: Blake Borgeson, Christopher Gibson, Tina Marriott Larson, Michael Secora, Shafique Virani, Tina Marriott, Mubadala Investment Co Pjsc, Dean Y Li, Gibson Christopher, Terry-Ann Burrell, and Zavain Dar
The most active insider trader at Recursion Pharmaceuticals Inc is Blake Borgeson with 53 trades.
Christopher Gibson has sold the most Recursion Pharmaceuticals Inc stock with a total value of $18,575,217.95.
Mubadala Investment Co Pjsc has bought the most Recursion Pharmaceuticals Inc stock with a total value of $3,191,575.00.
The most recent insider trade for Recursion Pharmaceuticals Inc was on Nov. 13, 2024.
The single biggest insider buy for Recursion Pharmaceuticals Inc was from Mubadala Investment Co Pjsc with a total value of $730,795.32 on Feb. 21, 2023.
The single biggest insider sell for Recursion Pharmaceuticals Inc was from Christopher Gibson with a total value of $2,190,000.00 on March 7, 2022.